Inequitable Conduct Ruling Against Synthon Upheld
A federal appeals court has rejected Synthon IP's challenge of a trial court's decision that two patents Synthon asserted against Pfizer Inc. in a case over the blockbuster blood pressure drug...To view the full article, register now.
Already a subscriber? Click here to view full article